Ashwagandha (KSM-66)
The flagship adaptogen of the modern stress-and-sleep category.
Standardized ashwagandha extracts (particularly branded KSM-66 and Sensoril) have become the dominant actives in stress, sleep, and cortisol-support formulas. Strong clinical file, recognizable brand extracts, and premium pricing support.
Ashwagandha (Withania somnifera) is an adaptogen with a long traditional-use history and a growing clinical evidence base for stress, cortisol, sleep quality, and athletic performance. The single biggest formulation decision brands face with ashwagandha is extract choice. KSM-66 and Sensoril are the two most recognized branded extracts, each with their own studies and consumer recognition, and they are meaningfully different products from generic root powder.
We help founders pick between generic and branded extracts, structure claims against whichever extract's clinical file they're using, and work through the regulatory differences between Canada (covered by an NPN monograph) and the USA (where some standardized forms have NDI considerations).
Why Brands Choose Ashwagandha (KSM-66)
Category leader in stress and sleep
Ashwagandha is now the default adaptogen consumers recognize, with KSM-66 and Sensoril commanding premium recognition.
Clinical file supports claims
Randomized trials on stress, cortisol, sleep quality, and exercise outcomes give brands defensible claim language.
Cross-category positioning
Stress, sleep, hormonal support, sports recovery, and cognitive. All plausible and evidence-supported positioning angles.
Formulation Notes
Working with Ashwagandha (KSM-66)
- Standard dose: 300–600 mg of standardized extract per day.
- Branded extracts (KSM-66, Sensoril) carry licensing fees but provide clinical studies and marketing collateral.
- Works well in capsules; bitter in powder and gummy formats unless masked.
- Combine with L-theanine or magnesium glycinate for sleep positioning.
Dosage Guidance
300–600 mg standardized extract daily. Morning for energy positioning, evening for sleep.
Delivery Forms
Regulatory Status
Canada (NPN)
Ashwagandha is monograph-covered for NPN with defined dose and claim ranges.
USA (DSHEA)
Sold as a dietary ingredient under DSHEA. Review NDI status for specific standardized forms.
Common Structure-Function Claims
- Helps relieve symptoms of stress
- Helps improve sleep quality
- Traditionally used in Ayurveda as Rasayana (rejuvenative)
Claim language must be reviewed for your specific product and market before use. Not all claims are permitted in every jurisdiction.
Clinical Evidence & Market Demand
Selected peer-reviewed studies, plus the demand signals we're seeing from founders, retailers, and consumer search behaviour.
Primary literature
Salve J, Pate S, Debnath K, Langade D. · Cureus · 2019
60-day RCT of KSM-66 at 250 mg and 600 mg. Both doses reduced PSS scores and morning cortisol vs placebo. The headline efficacy paper for KSM-66 stress claims.
Lopresti AL, Smith SJ, Malvi H, Kodgule R. · Medicine · 2019
Independent (non-supplier-funded) trial of Shoden ashwagandha showing improvements in stress, cortisol, sleep, and DHEA-S. Important for journalists and skeptics.
- Effects of ashwagandha (Withania somnifera) on physical performance: systematic review and Bayesian meta-analysisMeta-analysis
Bonilla DA, Moreno Y, Gho C, et al. · Journal of Functional Morphology and Kinesiology · 2021
Pooled trial evidence supporting strength, VO₂max, and recovery benefits. Bridges ashwagandha into sports nutrition positioning.
Chandrasekhar K, Kapoor J, Anishetty S. · Indian Journal of Psychological Medicine · 2012
The original KSM-66 stress trial. Set the dosing and outcome template that most subsequent trials follow.
Market & consumer demand
Ashwagandha has been the #1 botanical launch ingredient in US supplements two years running, with KSM-66 outselling generic root extracts at a roughly 3:1 ratio in DTC.
Ashwagandha hit the cultural moment about three years ago and hasn't faded. Which is unusual for a botanical. The reason is that the underlying problem (stress, sleep, cortisol) hasn't gone anywhere either. Consumers now ask for ashwagandha by name, often by branded extract. KSM-66 dominates US e-commerce listings; Sensoril holds in clinical/healthcare channels; Shoden has emerged as a premium third option. Generic root extract still sells in mass channels at price points 30–50% lower, but brand recognition for the branded extracts is strong enough to defend premium SKUs.
- Examine.com: Ashwagandha: Strong evidence for stress reduction and modest evidence for sleep and male testosterone support.
- Nutrition Business Journal: 2024 herbs & botanicals report: Identified ashwagandha as the fastest-growing single botanical for the third consecutive year.
References are provided for educational purposes. Citations do not constitute medical claims or guarantee outcomes. Structure-function claim language must be reviewed for your specific product and market.
Related Services
Ready to build with Ashwagandha (KSM-66)?
Tell us about your product concept and we'll put together a formulation, sourcing, and manufacturing plan tailored to your brand, format, and market.